[Infectious diseases during pregnancy (II). Diagnosis, prevention, fetal risks, therapeutic consequences].
Giovangrandi
Y
Y
Université René-Descartes, Paris V, Laboratoire d'immunologie des tumeurs URA 1484, CNRS.
Costa
J M
JM
Malka
D
D
Belein
V
V
D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000628:therapy / Q000635:transmission; D005260:Female; D005315:Fetal Diseases / Q000209:etiology*; D015658:HIV Infections / Q000175:diagnosis / Q000628:therapy / Q000635:transmission; D006509:Hepatitis B / Q000175:diagnosis / Q000628:therapy / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000382:microbiology / Q000628:therapy; D012307:Risk Factors; D013587:Syphilis / Q000175:diagnosis / Q000628:therapy / Q000635:transmission; D013590:Syphilis, Congenital / Q000175:diagnosis / Q000628:therapy
Maladies infectieuses au cours de la grossesse (II). Diagnostic, prévention, risques foetaux, conséquences thérapeutiques.